174 related articles for article (PubMed ID: 16630014)
41. Antibiotic resistance in triclosan tolerant fecal coliforms isolated from surface waters near wastewater treatment plant outflows (Morris County, NJ, USA).
Middleton JH; Salierno JD
Ecotoxicol Environ Saf; 2013 Feb; 88():79-88. PubMed ID: 23195806
[TBL] [Abstract][Full Text] [Related]
42. ucFabV Requires Functional Reductase Activity to Confer Reduced Triclosan Susceptibility in Escherichia coli.
Fischer TL; White RJ; Mares KF; Molnau DE; Donato JJ
J Mol Microbiol Biotechnol; 2015; 25(6):394-402. PubMed ID: 26683704
[TBL] [Abstract][Full Text] [Related]
43. Bacterial adaptation to biocides: the possible role of 'alarmones'.
Davies AJ; Maillard JY
J Hosp Infect; 2001 Dec; 49(4):300-2. PubMed ID: 11740885
[No Abstract] [Full Text] [Related]
44. Triclosan targets lipid synthesis.
McMurry LM; Oethinger M; Levy SB
Nature; 1998 Aug; 394(6693):531-2. PubMed ID: 9707111
[No Abstract] [Full Text] [Related]
45. A European survey of antimicrobial susceptibility among zoonotic and commensal bacteria isolated from food-producing animals.
Bywater R; Deluyker H; Deroover E; de Jong A; Marion H; McConville M; Rowan T; Shryock T; Shuster D; Thomas V; Vallé M; Walters J
J Antimicrob Chemother; 2004 Oct; 54(4):744-54. PubMed ID: 15375107
[TBL] [Abstract][Full Text] [Related]
46. Correlation between in vitro release from topical delivery vehicles and microbicidal activity of triclosan.
Swart HC; Du Preez JL; De Villiers MM; Lötter AP; Liebenberg W
Pharmazie; 2006 Jan; 61(1):35-40. PubMed ID: 16454204
[TBL] [Abstract][Full Text] [Related]
47. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?
Gilbert P; Allison DG; McBain AJ
Symp Ser Soc Appl Microbiol; 2002; (31):98S-110S. PubMed ID: 12481835
[TBL] [Abstract][Full Text] [Related]
48. Molecular basis of triclosan activity.
Levy CW; Roujeinikova A; Sedelnikova S; Baker PJ; Stuitje AR; Slabas AR; Rice DW; Rafferty JB
Nature; 1999 Apr; 398(6726):383-4. PubMed ID: 10201369
[No Abstract] [Full Text] [Related]
49. Prevalence and pattern of antimicrobial susceptibility in Escherichia coli isolated from pigs reared under antimicrobial-free and conventional production methods.
Bunner CA; Norby B; Bartlett PC; Erskine RJ; Downes FP; Kaneene JB
J Am Vet Med Assoc; 2007 Jul; 231(2):275-83. PubMed ID: 17630898
[TBL] [Abstract][Full Text] [Related]
50. Molecular characterization of antimicrobial resistance in enterococci and Escherichia coli isolates from European wild rabbit (Oryctolagus cuniculus).
Silva N; Igrejas G; Figueiredo N; Gonçalves A; Radhouani H; Rodrigues J; Poeta P
Sci Total Environ; 2010 Sep; 408(20):4871-6. PubMed ID: 20624632
[TBL] [Abstract][Full Text] [Related]
51. The antimicrobial properties of a urea-based handwash lotion with triclosan.
Tung FF; Estafan D; Scherer W
Gen Dent; 2001; 49(6):653-6. PubMed ID: 12024756
[TBL] [Abstract][Full Text] [Related]
52. In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens.
Chew BH; Cadieux PA; Reid G; Denstedt JD
J Endourol; 2006 Nov; 20(11):949-58. PubMed ID: 17144870
[TBL] [Abstract][Full Text] [Related]
53. Reduced Susceptibility of Proteus mirabilis to triclosan.
Stickler DJ; Jones GL
Antimicrob Agents Chemother; 2008 Mar; 52(3):991-4. PubMed ID: 18180352
[TBL] [Abstract][Full Text] [Related]
54. Triclosan and antibiotic resistance in Staphylococcus aureus.
Suller MT; Russell AD
J Antimicrob Chemother; 2000 Jul; 46(1):11-8. PubMed ID: 10882683
[TBL] [Abstract][Full Text] [Related]
55. Impact of hospitalization and antimicrobial drug administration on antimicrobial susceptibility patterns of commensal Escherichia coli isolated from the feces of horses.
Dunowska M; Morley PS; Traub-Dargatz JL; Hyatt DR; Dargatz DA
J Am Vet Med Assoc; 2006 Jun; 228(12):1909-17. PubMed ID: 16784384
[TBL] [Abstract][Full Text] [Related]
56. Triclosan Resistance in a Bacterial Fish Pathogen, Aeromonas salmonicida subsp. salmonicida, is Mediated by an Enoyl Reductase, FabV.
Khan R; Lee MH; Joo HJ; Jung YH; Ahmad S; Choi JH; Lee SW
J Microbiol Biotechnol; 2015 Apr; 25(4):511-20. PubMed ID: 25370725
[TBL] [Abstract][Full Text] [Related]
57. Outer membrane permeability for nonpolar antimicrobial agents underlies extreme susceptibility of Pasteurella multocida to the hydrophobic biocide triclosan.
Ellison ML; Champlin FR
Vet Microbiol; 2007 Oct; 124(3-4):310-8. PubMed ID: 17560745
[TBL] [Abstract][Full Text] [Related]
58. The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump.
Sanchez P; Moreno E; Martinez JL
Antimicrob Agents Chemother; 2005 Feb; 49(2):781-2. PubMed ID: 15673767
[TBL] [Abstract][Full Text] [Related]
59. Prevalence and genetic relatedness of antimicrobial-resistant Escherichia coli isolated from animals, foods and humans in Iceland.
Thorsteinsdottir TR; Haraldsson G; Fridriksdottir V; Kristinsson KG; Gunnarsson E
Zoonoses Public Health; 2010 May; 57(3):189-96. PubMed ID: 19912612
[TBL] [Abstract][Full Text] [Related]
60. An investigation of the impact of triclosan adaptation on Proteus mirabilis clinical isolates from an Egyptian university hospital.
Elekhnawy E; Sonbol F; Abdelaziz A; Elbanna T
Braz J Microbiol; 2021 Jun; 52(2):927-937. PubMed ID: 33826115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
